[2-R-(E,E)]-1-[2,3-DIHYDRO-3-METHYL-3-[(TRIMETHYLSILYL)-OXY]-2H-PYRAN-2-YL]-2-METHYL-4,6-OCTADIEN-3-ONE
Compound with spectra: 1 NMR
![[2-R-(E,E)]-1-[2,3-DIHYDRO-3-METHYL-3-[(TRIMETHYLSILYL)-OXY]-2H-PYRAN-2-YL]-2-METHYL-4,6-OCTADIEN-3-ONE](/api/compound/6IDNFQsF1ZU.png?ph=true&h=300&w=458 "[2-R-(E,E)]-1-[2,3-DIHYDRO-3-METHYL-3-[(TRIMETHYLSILYL)-OXY]-2H-PYRAN-2-YL]-2-METHYL-4,6-OCTADIEN-3-ONE")
| SpectraBase Compound ID | 6IDNFQsF1ZU |
|---|---|
| InChI | InChI=1S/C18H30O3Si/c1-7-8-9-11-16(19)15(2)14-17-18(3,12-10-13-20-17)21-22(4,5)6/h7-12,15,17H,13-14H2,1-6H3/b8-7+,11-9+/t15-,17-,18?/m1/s1 |
| InChIKey | UIVIYVNFYGWOSB-APFHEFAESA-N |
| Mol Weight | 322.52 g/mol |
| Molecular Formula | C18H30O3Si |
| Exact Mass | 322.196421 g/mol |
| Enantiomer InChIKey | UIVIYVNFYGWOSB-RNZLEDLVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(2RS,3RS)-3-(5-ETHANOYLTHIABUTYL)-2-PHENYL-3-[(TRIMETHYLSILYL)-OXY]-OXETANE
4a,5,6,7,8,8a-Hexahydro-4a-hydroxy-4-methyl-2H-1-benzopyran-2-one
2-Methoxy-10.alpha.-((trimethylsilyl)oxy)-(1H.beta.,6H.beta.)-bicyclo[4.4.1]undeca-2,4,8-triene
(4R,5S,6S)-5-(Benzyloxy)-6-[[(tert-butyldimethyldimethylsilyl)oxy]methyl]-4-methyltetrahydro-2-pyranone
GONIODIOL_8-MONOACETATE
(2S,3S,6S,4E)-3-TERT-BUTYLDIMETHYLSILYLOXY-6-HYDROXY-1,2-ISOPROPYLIDENDIOXYHENEICOS-4-ENE
(2S,3S,6R,4E)-3-TERT-BUTYLDIMETHYLSILYLOXY-6-HYDROXY-1,2-ISOPROPYLIDENDIOXYHENEICOS-4-ENE
(2RS,3RS)-3-(4-HYDROXYBUTYL)-2-PHENYL-3-[(TRIMETHYLSILYL)-OXY]-OXETANE
(2S,5S)-2-(1,1-Dimethyl-2-propenyl)-5-(tert-butyldiphenylsilyloxymethyl)tetrahydrofuran
Methyl 7-(2-(3-methoxy-1-octenyl)-3-methoxy-5-oxocyclopentyl)heptanoate
| Title | Journal or Book | Year |
|---|---|---|
| Stereocontrolled routes to functionalized [1,8-bc]naphthopyran. A study on the total synthesis of quassinoids and tetrahydronaphthalene antibiotics | The Journal of Organic Chemistry | 1993 |